These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30087937)

  • 1. Enhanced Intercellular Delivery of cRGD-siRNA Conjugates by an Additional Oligospermine Modification.
    Nakamoto K; Akao Y; Furuichi Y; Ueno Y
    ACS Omega; 2018 Jul; 3(7):8226-8232. PubMed ID: 30087937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure Tuning of Cationic Oligospermine-siRNA Conjugates for Carrier-Free Gene Silencing.
    Nothisen M; Bagilet J; Behr JP; Remy JS; Kotera M
    Mol Pharm; 2016 Aug; 13(8):2718-28. PubMed ID: 27398779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reductive nanocomplex encapsulation of cRGD-siRNA conjugates for enhanced targeting to cancer cells.
    Zhou Z; Liu S; Zhang Y; Yang X; Ma Y; Guan Z; Wu Y; Zhang L; Yang Z
    Int J Nanomedicine; 2017; 12():7255-7272. PubMed ID: 29042774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multivalent cyclic RGD conjugates for targeted delivery of small interfering RNA.
    Alam MR; Ming X; Fisher M; Lackey JG; Rajeev KG; Manoharan M; Juliano RL
    Bioconjug Chem; 2011 Aug; 22(8):1673-81. PubMed ID: 21755983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAMAM-cRGD mediating efficient siRNA delivery to spermatogonial stem cells.
    Li T; Chen Q; Zheng Y; Zhang P; Chen X; Lu J; Lv Y; Sun S; Zeng W
    Stem Cell Res Ther; 2019 Dec; 10(1):399. PubMed ID: 31852526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted systemic delivery of siRNA to cervical cancer model using cyclic RGD-installed unimer polyion complex-assembled gold nanoparticles.
    Yi Y; Kim HJ; Mi P; Zheng M; Takemoto H; Toh K; Kim BS; Hayashi K; Naito M; Matsumoto Y; Miyata K; Kataoka K
    J Control Release; 2016 Dec; 244(Pt B):247-256. PubMed ID: 27590214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Aib-Containing Amphipathic Helical Chain Length in MAP(Aib)-cRGD as Carrier for siRNA Delivery.
    Wada SI; Shibaike A; Hayashi J; Urata H
    Chem Biodivers; 2022 Feb; 19(2):e202100728. PubMed ID: 34842340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of cRGD conjugation at 5'-antisense strand of siRNA by phosphodiester linkage extension.
    Zhou X; Pan Y; Yu L; Wu J; Li Z; Li H; Guan Z; Tang X; Yang Z
    Mol Ther Nucleic Acids; 2021 Sep; 25():603-612. PubMed ID: 34589281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RGD-decorated cholesterol stabilized polyplexes for targeted siRNA delivery to glioblastoma cells.
    Lou B; Connor K; Sweeney K; Miller IS; O'Farrell A; Ruiz-Hernandez E; Murray DM; Duffy GP; Wolfe A; Mastrobattista E; Byrne AT; Hennink WE
    Drug Deliv Transl Res; 2019 Jun; 9(3):679-693. PubMed ID: 30972664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient silencing of EGFP reporter gene with siRNA delivered by asymmetrical N4,N9-diacyl spermines.
    Metwally AA; Reelfs O; Pourzand C; Blagbrough IS
    Mol Pharm; 2012 Jul; 9(7):1862-76. PubMed ID: 22129427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caged siRNAs with Single cRGD Modification for Photoregulation of Exogenous and Endogenous Gene Expression in Cells and Mice.
    Yu L; Liang D; Chen C; Tang X
    Biomacromolecules; 2018 Jul; 19(7):2526-2534. PubMed ID: 29727579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNAi-mediated gene knockdown and anti-angiogenic therapy of RCCs using a cyclic RGD-modified liposomal-siRNA system.
    Sakurai Y; Hatakeyama H; Sato Y; Hyodo M; Akita H; Ohga N; Hida K; Harashima H
    J Control Release; 2014 Jan; 173():110-8. PubMed ID: 24120854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multilayered polyion complexes with dissolvable silica layer covered by controlling densities of cRGD-conjugated PEG chains for cancer-targeted siRNA delivery.
    Naito M; Azuma R; Takemoto H; Hori M; Yoshinaga N; Osawa S; Kamegawa R; Kim HJ; Ishii T; Nishiyama N; Miyata K; Kataoka K
    J Biomater Sci Polym Ed; 2017; 28(10-12):1109-1123. PubMed ID: 28278046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actively-targeted polyion complex micelles stabilized by cholesterol and disulfide cross-linking for systemic delivery of siRNA to solid tumors.
    Oe Y; Christie RJ; Naito M; Low SA; Fukushima S; Toh K; Miura Y; Matsumoto Y; Nishiyama N; Miyata K; Kataoka K
    Biomaterials; 2014 Sep; 35(27):7887-95. PubMed ID: 24930854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of a siRNA Carrier Modified with a pH-Sensitive Cationic Lipid and a Cyclic RGD Peptide for Efficiently Targeting Tumor Endothelial Cells.
    Hada T; Sakurai Y; Harashima H
    Pharmaceutics; 2015 Sep; 7(3):320-33. PubMed ID: 26389942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of siRNAs incorporated with cationic peptides R8G7 and R8A7 and the effect of the modifications on siRNA properties.
    Matsubara M; Honda K; Ozaki K; Kajino R; Kakisawa Y; Maeda Y; Ueno Y
    RSC Adv; 2020 Sep; 10(57):34815-34824. PubMed ID: 35514421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cationic Oligospermine-Oligonucleotide Conjugates Provide Carrier-free Splice Switching in Monolayer Cells and Spheroids.
    Nothisen M; Perche-Létuvée P; Behr JP; Remy JS; Kotera M
    Mol Ther Nucleic Acids; 2018 Dec; 13():483-492. PubMed ID: 30388622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctional polyion complex micelle featuring enhanced stability, targetability, and endosome escapability for systemic siRNA delivery to subcutaneous model of lung cancer.
    Kim HJ; Ishii T; Zheng M; Watanabe S; Toh K; Matsumoto Y; Nishiyama N; Miyata K; Kataoka K
    Drug Deliv Transl Res; 2014 Feb; 4(1):50-60. PubMed ID: 25786617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of BCR/ABL Chimeric Gene in Human Chronic Myelogenous Leukemia Cell Line K562 by siRNA-Nuclear Export Signal Peptide Conjugates.
    Shinkai Y; Kashihara S; Minematsu G; Fujii H; Naemura M; Kotake Y; Morita Y; Ohnuki K; Fokina AA; Stetsenko DA; Filichev VV; Fujii M
    Nucleic Acid Ther; 2017 Jun; 27(3):168-175. PubMed ID: 28355131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction of a Targeting Nanoparticle of 3',3″-Bis-Peptide-siRNA Conjugate/Mixed Lipid with Postinserted DSPE-PEG2000-cRGD.
    Zhang Y; Li S; Zhou X; Sun J; Fan X; Guan Z; Zhang L; Yang Z
    Mol Pharm; 2019 Dec; 16(12):4920-4928. PubMed ID: 31642677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.